Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)
2022 · EClinicalMedicine · 37 citations
https://doi.org/10.1016/j.eclinm.2022.101409
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
2.0K
Citations
17
h-index
21
i10-index
Mariam Aziz is an academic researcher. The author has contributed to research in topics: HIV/AIDS Research and Interventions & Respiratory viral infections research & Long-Term Effects of COVID-19. The author has an h-index of 17, co-authored 38 publications.
https://doi.org/10.1016/j.eclinm.2022.101409
https://doi.org/10.1007/s40119-020-00201-7
Click to start Chat